Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.
Klonowska K, Thiele EA, Grevelink JM, Thorner AR, Kwiatkowski DJ.
J Med Genet. 2022 Sep;59(9):920-923. doi: 10.1136/jmedgenet-2021-108160. Epub 2021 Oct 11.
Tuberous Sclerosis Complex: A Review.
Randle SC.
Pediatr Ann. 2017 Apr 1;46(4):e166-e171. doi: 10.3928/19382359-20170320-01.
Tuberous Sclerosis Complex.
Islam MP.
Semin Pediatr Neurol. 2021 Apr;37:100875. doi: 10.1016/j.spen.2021.100875. Epub 2021 Feb 11.
Tuberous sclerosis.
Curatolo P, Bombardieri R, Jozwiak S.
Lancet. 2008 Aug 23;372(9639):657-68. doi: 10.1016/S0140-6736(08)61279-9.
Facial Angiofibroma Severity Index: A beneficial tool to evaluate the treatment response in the skin of colour.
Hongal AA, Aithal SS, Revathi TN.
Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):130-132. doi: 10.25259/IJDVL_1161_2021.
Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
Boggarapu S, Roberds SL, Nakagawa J, Beresford E.
Orphanet J Rare Dis. 2022 Sep 14;17(1):355. doi: 10.1186/s13023-022-02496-2.
Tuberous sclerosis complex: review based on new diagnostic criteria.
Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM.
An Bras Dermatol. 2018 Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972.
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ, Heunis TM, Vanclooster S, Chambers N, Bissell S, Byars AW, Flinn J, Gipson TT, van Eeghen AM, Waltereit R, Capal JK, Cukier S, Davis PE, Smith C, Kingswood JC, Schoeters E, Srivastava S, Takei M, Gardner-Lubbe S, Kumm AJ, Krueger DA, Sahin M, De Waele L, Jansen AC.
J Neurodev Disord. 2023 Sep 14;15(1):32. doi: 10.1186/s11689-023-09500-1.
Tuberous Sclerosis Complex.
Zhang LW, Chen T.
J Cutan Med Surg. 2023 Nov;27(6):674. doi: 10.1177/12034754231174851. Epub 2023 May 17.
A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blind randomized placebo-controlled trial.
Aitken P, Stanescu I, Boddington L, Mahon C, Fogarasi A, Liao YH, Ivars M, Moreno-Artero E, Trauner D, DeRoos ST, Jancic J, Nikolic M, Balážová P, Price HN, Hadzsiev K, Riney K, Stapleton S, Tollefson MM, Bauer D, Pinková B, Atkinson H.
Br J Dermatol. 2023 Oct 25;189(5):520-530. doi: 10.1093/bjd/ljad243.
